Skip to main content
. 2012 Feb 16;7(2):e31501. doi: 10.1371/journal.pone.0031501

Figure 5. Determination of analytes contributing significantly to separation between AD patients and healthy controls by O-PLS-DA of the CSF data set.

Figure 5

(A) OPLS-DA score plot for light AD patients (MMSE>22) vs. controls. (B) OPLS-DA coefficient plot for light AD patients (MMSE>22) vs. controls. Cysteine and uridine are the most relevant analytes for separating light AD patients (MMSE>22) from healthy subjects.